# Treating Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Ablation or Medication

> **NCT07272902** · NA · RECRUITING · sponsor: **Nova Scotia Health Authority** · enrollment: 84 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)
- Heart Failure With Mildly Reduced Ejection Fraction
- Heart Failure With Preserved Ejection Fraction (HFPEF)
- Rate Control
- Rhythm Control

## Interventions

- **PROCEDURE:** Catheter Ablation for Atrial Fibrillation
- **DRUG:** Rate Control Medications (beta-blockers, calcium channel blockers, digoxin)

## Key facts

- **NCT ID:** NCT07272902
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2027-10
- **Final completion:** 2027-10
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07272902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07272902, "Treating Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Ablation or Medication". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07272902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*